Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RET-oncogene-targeting drugs draw notice.

Nature biotechnology - 9 Nov 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anilides
Share to Antineoplastic Agents
Share to Drug Delivery Systems
Share to Mutation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Oncogene Proteins, Fusion

Share to Proto-Oncogene Proteins c-ret

Share to Pyridines

Source

Identifiers

PMID: 29121012
DOI: 10.1038/nbt1117-996

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 18 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RET-oncogene-targeting drugs draw notice.PMID 29121012Read ↗

RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectivesSemantic proximity Read ↗

RET Signaling Pathway in Human Cancer: Oncogenic Mechanisms, Selective Inhibitors, and Emerging Resistance Strategies.Semantic proximity Read ↗

Oncogenes for the oncologist.Semantic proximity Read ↗

Targeting RET alterations in cancer: Recent progress and future directions.Semantic proximity Read ↗

Thyroid cancer in 2010: a roadmap for targeted therapies.Semantic proximity Read ↗

RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future.Semantic proximity Read ↗

Precision oncology for RET-related tumorsSemantic proximity Read ↗

State-of-the-Art Strategies for Targeting RET -Dependent CancersSemantic proximity Read ↗

[Cancer targeted therapy and resistance signals].Semantic proximity Read ↗

RET alterations in thyroid cancer: Molecular mechanisms, targeted therapies, and emerging resistance.Semantic proximity Read ↗

Hyperactivation of oncogenic driver pathways as a precision therapeutic strategy.Semantic proximity Read ↗

Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.